Breast Cancer: The Past, the Present, and a Look Towards the Future.
The file is restricted.
Please click here to access the YU-community-only item.
MetadataShow full item record
The file is restricted for YU community access only.
Breast cancer is a multifactorial and complicated disease with many risk factors, subcategories, and therapy options. The current methods of therapy cause great harm to the woman they are attempting to heal and their success in healing is inconsistent. Researchers disagree on which treatment options are most successful for each subclass of breast cancer. Tamoxifen, for example, is regarded by some as a highly successful therapy for estrogen-receptor positive breast cancers. Other researchers however, think Tamoxifen does more harm than it does good and should not be used. This is one of several similar controversies discussed in this thesis (other include whether estrogen should be upregulated or down-regulated, whether self and clinical breast screening are beneficial or dangerous etc.). The thesis will address the many opinions surrounding important decisions in breast cancer treatment and suggest that a more systemized method (genomic screening) should be used to determine when each treatment option will be successful and when it will be resisted. It will also suggest future success trends in breast cancer treatment, mainly the development of the immunotherapy treatment method which will reduce resistance and harsh side effects and promote successful healing in even the most challenging cases.
Israel, Adina. Breast Cancer: The Past, the Present, and a Look Towards the Future Presented to the S. Daniel Abraham Honors Program in Partial Fulfillment of the Requirements for Completion of the Program Stern College for Women Yeshiva University June 14, 2019.
*This is contructed from limited avaiable data and may be imprecise.
The file is restricted. Please click here to access the YU-community-only item.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States
Showing items related by title, author, creator and subject.
Targeting Dormant Chemo Resistant Breast Cancer Micro Metastasis A Study of Drug Resistance in Invasive Cancer Cells Jay, Joshua A. (Yeshiva College, 2010-08)Breast cancer is one of the most common forms of cancer worldwide. In the United States, a woman has a one in eight chance of developing invasive breast cancer in her lifetime and a one in thirty-five chance of dying of ...
Stobezki, Robert (Yeshiva College, 2010-08)The major challenges faced by breast cancer clinicians are metastasis and drug resistance, which cause a high rate of morbidity and mortality. Tumor cells can detach and give rise to micro metastases, which usually go ...
Khalil, Bassem (ProQuest Dissertations & Theses, 2016)p110beta, the catalytic subunit of P13Kbeta, is an isoform of phosphoinositide 3-kinase (PI3K), a family of lipid kinases that control critical cellular functions, including proliferation, growth, metabolism, and migration. ...